Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Etiology of hypokalemic paralysis in Korea: data from a single center.

Wi JK, Lee HJ, Kim EY, Cho JH, Chin SO, Rhee SY, Moon JY, Lee SH, Jeong KH, Ihm CG, Lee TW.

Electrolyte Blood Press. 2012 Dec;10(1):18-25. doi: 10.5049/EBP.2012.10.1.18. Epub 2012 Dec 31.

2.

Comparative study of thyrotoxic periodic paralysis from idiopathic hypokalemic periodic paralysis: An experience from India.

Kalita J, Goyal G, Bhoi SK, Chandra S, Misra UK.

Ann Indian Acad Neurol. 2012 Jul;15(3):186-90. doi: 10.4103/0972-2327.99708.

3.

[Hypokalemic and thyrotoxic paralysis--similarities and differences].

Ziora K.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(4):249-52. Review. Polish.

PMID:
16232364
4.

Clinical features and recovery patterns of acquired non-thyrotoxic hypokalemic paralysis.

Hiraga A, Kamitsukasa I, Kojima K, Kuwabara S.

J Neurol Sci. 2012 Feb 15;313(1-2):42-5. doi: 10.1016/j.jns.2011.09.034. Epub 2011 Oct 13.

PMID:
22000401
5.

Diagnosing thyrotoxic periodic paralysis in the ED.

Lin YF, Wu CC, Pei D, Chu SJ, Lin SH.

Am J Emerg Med. 2003 Jul;21(4):339-42.

PMID:
12898495
6.

Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio.

Lin SH, Chu P, Cheng CJ, Chu SJ, Hung YJ, Lin YF.

Crit Care Med. 2006 Dec;34(12):2984-9.

PMID:
16971853
7.

Thyrotoxic periodic paralysis: a report of 3 Malaysian cases and a review of its pathology.

Sthaneshwar P, Prathibha R, Yap SF.

Malays J Pathol. 2005 Jun;27(1):29-32.

PMID:
16676690
8.
9.

Hypokalemic paralysis following administration of intravenous methylprednisolone in a patient with Graves' thyrotoxicosis and ophthalmopathy.

Tigas S, Papachilleos P, Ligkros N, Andrikoula M, Tsatsoulis A.

Hormones (Athens). 2011 Oct-Dec;10(4):313-6.

10.

Hypokalaemia and paralysis in the Thai population.

Phakdeekitcharoen B, Ruangraksa C, Radinahamed P.

Nephrol Dial Transplant. 2004 Aug;19(8):2013-8. Epub 2004 Jun 8.

PMID:
15187194
11.

Hypokalemic thyrotoxic periodic paralysis: a case series.

Wong P.

CJEM. 2003 Sep;5(5):353-5.

PMID:
17466146
12.

Drug-induced thyrotoxic periodic paralysis.

Kane MP, Busch RS.

Ann Pharmacother. 2006 Apr;40(4):778-81. Epub 2006 Mar 14.

PMID:
16537816
13.

Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes.

Manoukian MA, Foote JA, Crapo LM.

Arch Intern Med. 1999 Mar 22;159(6):601-6.

PMID:
10090117
14.

Analytic review: thyrotoxic periodic paralysis: a review.

Pothiwala P, Levine SN.

J Intensive Care Med. 2010 Mar-Apr;25(2):71-7. doi: 10.1177/0885066609358849. Epub 2010 Jan 19. Review.

PMID:
20089526
15.

Thyrotoxic periodic paralysis.

Balakrishnan RK, Chandran SR, Thirumalnesan G, Doraisamy N.

Indian J Endocrinol Metab. 2011 Jul;15(Suppl 2):S147-9. doi: 10.4103/2230-8210.83360.

16.
17.

Mutation screening in Chinese hypokalemic periodic paralysis patients.

Wang W, Jiang L, Ye L, Zhu N, Su T, Guan L, Li X, Ning G.

Mol Genet Metab. 2006 Apr;87(4):359-63. Epub 2006 Jan 4.

PMID:
16386935
18.

Thyrotoxic periodic paralysis in a Caucasian man in treatment for Graves' disease.

Didonna D, D'Alessandro G, De Michele A, Conte M, Storelli A, Totaro M, Altomare E.

Panminerva Med. 2000 Dec;42(4):293-4.

PMID:
11294094
19.

[Thyrotoxic periodic paralysis: a case report].

Vale J, Canas N, Leal A, Vilar H.

Acta Med Port. 2005 Sep-Oct;18(5):399-402. Epub 2005 Oct 16. Portuguese.

20.

Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis.

Hsu YJ, Lin YF, Chau T, Liou JT, Kuo SW, Lin SH.

Am J Med Sci. 2003 Sep;326(3):128-32.

PMID:
14501227

Supplemental Content

Support Center